TAMARA L JOSEPH
CIK 1433991 · Chief Legal Officer · last filed 2024-02-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$708.8K
Companies
4
Total Filings
33
Lifetime Open-Market Net
-$874.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SPRO | Chief Legal Officer | 562,521 | $1.26 | $708.8K | -$51.0K | 6 | 2024-02-05 |
| Tempest Therapeutics, Inc. (MLND) Delisted | General Counsel and Secretary | — | $15.90 | — | $0 | 3 | 2020-05-27 |
| INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted | SVP, General Counsel | — | $0.32 | — | $0 | 3 | 2017-01-20 |
| CUBIST PHARMACEUTICALS INC (CBST) Delisted | SVP, GC & Secretary | 19,699 | — | — | -$823.2K | 19 | 2012-07-03 |
Recent Filings · Page 3 of 4
33 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-07-05 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Other (J) | +1,142 | $21.2K | EDGAR |
| 2011-05-17 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Mixed | +3,825 | $0 | EDGAR |
| 2011-04-04 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Other (J) | +437 | $11.0K | EDGAR |
| 2010-07-02 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Other (J) | +1,332 | $21.6K | EDGAR |
| 2010-05-18 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Mixed | +1,200 | $0 | EDGAR |
| 2010-04-01 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Other (J) | +473 | $10.7K | EDGAR |
| 2009-07-02 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Other (J) | +1,126 | $17.9K | EDGAR |
| 2009-05-19 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-04-02 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Other (J) | +531 | $8.7K | EDGAR |
| 2009-01-05 | CUBIST PHARMACEUTICALS INC (CBST) Delisted | Other (J) | +1,367 | $21.2K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.